Fidelity Advisor Equity Growth Fund RPRX Holdings History
Fidelity Advisor Equity Growth Fund's Royalty Pharma PLC Holding Summary
As of 2025-02-28, FIDELITY ADVISOR SERIES I held 3.72 Mil shares of Royalty Pharma PLC(RPRX), totaling $125.31 Mil. This investment constitutes 1.11% of their stock portfolio, and FIDELITY ADVISOR SERIES I now holds 0.88% of the outstanding Royalty Pharma PLC(RPRX) stock.
The initial trade took place in 2025Q1. And since then Fidelity Advisor Equity Growth Fund has made 1 purchases of RPRX, at an average price of $29.04, for a total of 3.72 Mil shares. Based on historical transaction data and RPRX's current price of $35.59, Fidelity Advisor Equity Growth Fund's estimated gain on his RPRX holdings is $24.40 Mil, reflecting a 22.56% gain to date.
Fidelity Advisor Equity Growth Fund RPRX ($35.59) Holding Chart
Fidelity Advisor Equity Growth Fund RPRX ($35.59) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
